Potential for airborne contamination in turbulent- and unidirectional- airflow compounding aseptic isolators

American Journal of Health-System Pharmacy

Volumn 64, Issue 6, 2007, Pages 622-631

  Peters, Gregory F ^a,c   McKeon, Marghi R ^a   Weiss, William T ^b  

^a Lab Safety Corporation   (United States)

^b MAYO CLINIC   (United States)

^c Lab Safety Corporation   (United States)

Author keywords

Air; Aseptic areas; Compounding; Contamination; Control, quality; Equipment; Sterile products

Indexed keywords

DRUG;

AIRFLOW; ARTICLE; DEVICE; DISINFECTION; DRUG CONTAMINATION; DRUG FORMULATION; DRUG QUALITY; DRUG STERILITY; PRIORITY JOURNAL; QUALITY CONTROL; TURBULENT FLOW;

EID: 33947580633     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp060067     Document Type: Article

References (18)

1. Pharmaceutical compounding-sterile preparations (general information chapter 797). In: The United States pharmacopeia, 28th rev., and The national formulary, 23rd ed. Rockville, MD: United States Pharmacopeial Convention; 2005:2461-77.
2. Compounding aseptic isolator testing guide CAG-002-2006. Raleigh, NC: Controlled Environment Testing Association; 2006.
3. Food and Drug Administration. Guidance to industry: sterile drug products produced by aseptic processing. www.fda.gov/cber/gdlns/steraseptic.htm (accessed 2006 Dec 20).
4. NSF International. NSF/ANSI standard 49 class II (laminar flow) biosafety cabinetry. Ann Arbor, MI: NSF International; 2003.
5. Valiteq compounding manual. Cumberland, WI: Lab Safety Corporation; 2000:2:13.
6. Food and Drug Administration. Warning letter WL-320-99-03 to Eli Lilly Italia. www.fda.gov/foi/warning_letters/m2668n.pdf (accessed 2006 Dec 20).
7. Food and Drug Administration. Warning letter WL-320-05-03 to ACS Dobfar, Inc. www.fda.gov/foi/warning_letters/g5418d.pdf (accessed 2006 Dec 20).
8. Design and validation of isolator systems for the manufacturing and testing of health care products. Technical report no. 34. Bethesda, MD: Parenteral Drug Association; 2001.
9. IEST-RP-CC-006.3: testing cleanrooms. Rolling Meadows, IL: Institute of Environmental Sciences; 2005.
10. Peters GF. Laminar airflow equipment: theory and applications. In: Swarbrick J, Boylan JC, eds. Encyclopedia of pharmaceutical technology. 2nd ed. Vol. 2. New York: Marcel Dekker; 2002.
11. Controlled Environment Testing Association. Applications guide for the use of compounding isolators in compounding sterile preparations in healthcare facilities. CAG-001-2005. www.cetainternational.org/reference/ ApplicationsGuideBarrierIsolator110805.pdf (accessed 2006 Dec 20).
12. Standard 14644-7. Clean room and associated controlled environments-part 7: separative devices (clean air hoods, glove-boxes, isolators and mini environments). Geneva, Switzerland: International Standards Organization; 2004.
13. Rahe H. Understanding the critical components of a successful clean room and compounding aseptic isolator project. www.mic4.com/articles/understanding- components.php (accessed 2006 Dec 20).
14. Wagner JT. Does your compounding aseptic isolator isolate? www.pppmag.com/documents/V2N6/V2N6_pp/2BarrierIsolators.pdf (accessed 2006 Dec 20).
15. Safe compounding of hazardous drugs manual. 2nd ed. Cumberland, WI: Lab Safety Corporation; 2000.
16. Hiom SJ. Validation of disinfection techniques in hospital aseptic dispensing units. www.pjonline.com/editorial/20000819/papers/disinfection. html (accessed 2006 Dec 20).
17. Hiom S, Lowe C, Oldcorne M. Development and validation of a method to assess alcohol transfer disinfection procedures. www.pjonline.com/pdf/papers/ pj_20040515_alcoholtransfer.pdf (accessed 2006 Dec 20).
18. Akhtar MK, Xiong Y, Pratsinis SE. Vapor synthesis of titania powder by titanium tetrachloride oxidation. J Am Inst Chem Eng. 1991; 37:1561-70.